US 11331333
Treatment of aberrant fibroblast proliferation
granted A61KA61K31/343A61K31/713
Quick answer
US patent 11331333 (Treatment of aberrant fibroblast proliferation) held by The Board of Regents of the University of Texas System expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/343, A61K31/713